Olivia Eckart

Goethe University Frankfurt

Papers

1

Total Citations

7

H-Index

1

About

Dr. Olivia Eckart is a rising surgical oncologist whose work centers on optimizing outcomes in urologic oncology, with a particular focus on renal cell carcinoma (RCC). Her research rigorously compares surgical approaches to partial nephrectomy, the gold-standard treatment for resectable kidney tumors. In her landmark 2023 study, a propensity-matched analysis of peri- and intraoperative outcomes, Dr. Eckart directly addressed the critical, often subjective decision between robotic-assisted (RAPN) and open (OPN) partial nephrectomy. By controlling for inherent surgeon bias and patient selection, her work provides much-needed, objective data to guide clinical practice. This study has already garnered 7 citations, signaling its immediate impact on the field. Dr. Eckart’s contributions are particularly vital as robotic surgery becomes more prevalent; her evidence-based comparisons help define the true benefits and trade-offs of each technique, ultimately empowering surgeons to make more informed, patient-centered decisions. Her research is a cornerstone for anyone studying the evolution of minimally invasive cancer surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of peri- and intraoperative outcomes of open vs robotic-assisted partial nephrectomy for renal cell carcinoma: a propensity-matched analysis
7 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Goethe University Frankfurt

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago